Determination of tamoxifen and metabolites in serum by capillary electrophoresis using a nonaqueous buffer system.
Tamoxifen (TAM), an antiestrogen, is widely used to treat hormone-dependent breast cancer in post-menopausal women. TAM may be used as a chemopreventive agent in women of child-bearing age; however, few data exist describing potential TAM-induced fetal toxicity. In support of the National Toxicology Program's characterization of reproductive and developmental effects of TAM, this work describes an analytical technique utilizing capillary electrophoresis (CE) for the detection of circulating levels of TAM, N-desmethyltamoxifen (DMT), and 4-hydroxytamoxifen (4-HT) in maternal rodent serum. Greater than 90% of 3H-labeled TAM was extractable from serum using 98:2 hexane-isoamyl alcohol. Optimum separation of TAM, DMT, and 4-HT was obtained on a 57 cmx50 microm capillary using a nonaqueous buffer system of 1:1 methanol-acetonitrile containing 50 mM ammonium acetate and 1% acetic acid. 4-Dimethylaminopyridine was used as internal standard. Temperature and voltage were optimized at 40 degrees C and 15 kV, respectively. The limit of detection of TAM by UV detection at 214 nm was approximately 800 amol. TAM and DMT were confirmed in serum of female rats 4 h following a single oral dose of 120 mg/kg. Transplacental exposure of TAM to fetal tissue will be evaluated using this technique.
Sanders
J M
JM
National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.
Burka
L T
LT
Shelby
M D
MD
Newbold
R R
RR
Cunningham
M L
ML
D000818:Animals; D016588:Anticarcinogenic Agents / Q000097:blood*; D002021:Buffers; D019075:Electrophoresis, Capillary; D005260:Female; D051381:Rats; D011916:Rats, Inbred F344; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000097:blood*
D016588:Anticarcinogenic Agents; D002021:Buffers; D013629:Tamoxifen; C016601:afimoxifene; C028787:N-desmethyltamoxifen